{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:32:21Z","timestamp":1786365141000,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10176-1","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:34:06Z","timestamp":1779186846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tetrameric assembly disruption impairs CXCL4 chaperon ability for DNA and type I interferon immune amplification"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4711-4122","authenticated-orcid":false,"given":"Giuseppe","family":"Ocone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mennella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Pietraforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca R.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0729-8001","authenticated-orcid":false,"given":"Lucia","family":"Gaddini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Stefanantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5144-2552","authenticated-orcid":false,"given":"Ernest Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C. L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6924-3826","authenticated-orcid":false,"given":"Loredana","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"10176_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/nrrheum.2014.53","volume":"10","author":"YY Ho","year":"2014","unstructured":"Ho, Y. Y., Lagares, D., Tager, A. M. & Kapoor, M. Fibrosis\u2014a lethal component of systemic sclerosis. Nat. Rev. Rheumatol. 10, 390\u2013402 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10176_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton, C. P. & Khanna, D. Systemic sclerosis.  Lancet 390, 1685\u20131699 (2017).","journal-title":"Lancet"},{"key":"10176_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09683-z","volume":"10","author":"R Lande","year":"2019","unstructured":"Lande, R. et al. CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis. Nat. Commun. 10, 1731 (2019).","journal-title":"Nat. Commun."},{"key":"10176_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cei.13426","volume":"201","author":"L Frasca","year":"2020","unstructured":"Frasca, L. & Lande, R. Toll-like receptors in mediating pathogenesis in systemic sclerosis. Clin. Exp. Immunol. 201, 14\u201324 (2020).","journal-title":"Clin. Exp. Immunol."},{"key":"10176_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pharmthera.2018.08.003","volume":"192","author":"J Henderson","year":"2018","unstructured":"Henderson, J., Bhattacharyya, S., Varga, J. & O\u2019Reilly, S. Targeting TLRs and the inflammasome in systemic sclerosis. Pharm. Ther. 192, 163\u2013169 (2018).","journal-title":"Pharm. Ther."},{"key":"10176_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nmat4298","volume":"14","author":"NW Schmidt","year":"2015","unstructured":"Schmidt, N. W. et al. Liquid-crystalline ordering of antimicrobial peptide\u2013DNA complexes controls TLR9 activation. Nat. Mater. 14, 696\u2013700 (2015).","journal-title":"Nat. Mater."},{"key":"10176_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cis.2016.02.003","volume":"232","author":"EY Lee","year":"2016","unstructured":"Lee, E. Y. et al. A review of immune amplification via ligand clustering by self-assembled liquid\u2013crystalline DNA complexes. Adv. Colloid Interface Sci. 232, 17\u201324 (2016).","journal-title":"Adv. Colloid Interface Sci."},{"key":"10176_CR8","doi-asserted-by":"publisher","first-page":"e1006315","DOI":"10.1371\/journal.ppat.1006315","volume":"13","author":"SA Tursi","year":"2017","unstructured":"Tursi, S. A. et al. Bacterial amyloid curli acts as a carrier for DNA to elicit an autoimmune response via TLR2 and TLR9. PLOS Pathog. 13, e1006315 (2017).","journal-title":"PLOS Pathog."},{"key":"10176_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08868-w","volume":"10","author":"EY Lee","year":"2019","unstructured":"Lee, E. Y. et al. Helical antimicrobial peptides assemble into protofibril scaffolds that present ordered dsDNA to TLR9. Nat. Commun. 10, 1012 (2019).","journal-title":"Nat. Commun."},{"key":"10176_CR10","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1021\/bi00193a025","volume":"33","author":"X Zhang","year":"1994","unstructured":"Zhang, X., Chen, L., Bancroft, D. P., Lai, C. K. & Maione, T. E. Crystal structure of recombinant human platelet factor 4. Biochemistry 33, 8361\u20138366 (1994).","journal-title":"Biochemistry"},{"key":"10176_CR11","doi-asserted-by":"publisher","first-page":"20508","DOI":"10.1074\/jbc.272.33.20508","volume":"272","author":"SE Stringer","year":"1997","unstructured":"Stringer, S. E. & Gallagher, J. T. Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate*. J. Biol. Chem. 272, 20508\u201320514 (1997).","journal-title":"J. Biol. Chem."},{"key":"10176_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1541-7786.MCR-09-0176","volume":"8","author":"J Vandercappellen","year":"2010","unstructured":"Vandercappellen, J. et al. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1\/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo. Mol. Cancer Res. 8, 322\u2013334 (2010).","journal-title":"Mol. Cancer Res."},{"key":"10176_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2010.10.011","volume":"22","author":"J Vandercappellen","year":"2011","unstructured":"Vandercappellen, J., Van Damme, J. & Struyf, S. The role of the CXC chemokines platelet factor-4 (CXCL4\/PF-4) and its variant (CXCL4L1\/PF-4var) in inflammation, angiogenesis and cancer. Cytokine Growth Factor Rev. 22, 1\u201318 (2011).","journal-title":"Cytokine Growth Factor Rev."},{"key":"10176_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06116","volume":"449","author":"R Lande","year":"2007","unstructured":"Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564\u2013569 (2007).","journal-title":"Nature"},{"key":"10176_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01759-2","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles. Nat. Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-024-01759-2 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"10176_CR16","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1073\/pnas.92.17.7799","volume":"92","author":"SK Gupta","year":"1995","unstructured":"Gupta, S. K., Hassel, T. & Singh, J. P. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. Natl. Acad. Sci. USA 92, 7799\u20137803 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10176_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.24272\/j.issn.2095-8137.2022.464","volume":"44","author":"J Pan","year":"2023","unstructured":"Pan, J. et al. Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases. Zool. Res 44, 183\u2013218 (2023).","journal-title":"Zool. Res"},{"key":"10176_CR18","first-page":"37","volume":"12","author":"P Freedman","year":"2025","unstructured":"Freedman, P. et al. Extracellular BAG3 is elevated in early diffuse systemic sclerosis. Mil. Med Res. 12, 37\u201340 (2025).","journal-title":"Mil. Med Res."},{"key":"10176_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","volume":"105","author":"L Rauova","year":"2005","unstructured":"Rauova, L. et al. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood 105, 131\u2013138 (2005).","journal-title":"Blood"},{"key":"10176_CR20","first-page":"312","volume":"26","author":"DP Dyer","year":"2016","unstructured":"Dyer, D. P., Salanga, C. L., Volkman, B. F., Kawamura, T. & Handel, T. M. The dependence of chemokine\u2013glycosaminoglycan interactions on chemokine oligomerization. Glycobiology 26, 312\u2013326 (2016).","journal-title":"Glycobiology"},{"key":"10176_CR21","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1182\/blood-2012-01-406801","volume":"119","author":"BS Sachais","year":"2012","unstructured":"Sachais, B. S. et al. Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia. Blood 119, 5955\u20135962 (2012).","journal-title":"Blood"},{"key":"10176_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev.med.042808.171814","volume":"61","author":"GM Arepally","year":"2010","unstructured":"Arepally, G. M. & Ortel, T. L. Heparin-Induced Thrombocytopenia. Annu. Rev. Med. 61, 77\u201390 (2010).","journal-title":"Annu. Rev. Med."},{"key":"10176_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1084\/jem.185.6.1101","volume":"185","author":"G Grouard","year":"1997","unstructured":"Grouard, G. et al. The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand. J. Exp. Med 185, 1101\u20131112 (1997).","journal-title":"J. Exp. Med"},{"key":"10176_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13075-017-1498-3","volume":"20","author":"CC Mok","year":"2018","unstructured":"Mok, C. C. et al. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Arthritis Res Ther. 20, 6 (2018).","journal-title":"Arthritis Res Ther."},{"key":"10176_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","volume":"15","author":"N Kasitanon","year":"2006","unstructured":"Kasitanon, N., Fine, D. M., Haas, M., Magder, L. S. & Petri, M. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15, 366\u2013370 (2006).","journal-title":"Lupus"},{"key":"10176_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jdermsci.2025.01.002","volume":"117","author":"T Steadman","year":"2025","unstructured":"Steadman, T. & O\u2019Reilly, S. Aberrant fumarate metabolism links interferon release in diffuse systemic sclerosis. J. Dermatol Sci. 117, 30\u201335 (2025).","journal-title":"J. Dermatol Sci."},{"key":"10176_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2133.2002.48901.x","volume":"147","author":"L Beretta","year":"2002","unstructured":"Beretta, L., Caronni, M., Vanoli, M. & Scorza, R. Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders. Br. J. Dermatol. 147, 385\u2013385 (2002).","journal-title":"Br. J. Dermatol."},{"key":"10176_CR28","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/art.23486","volume":"58","author":"D Kim","year":"2008","unstructured":"Kim, D. et al. Induction of interferon-\u03b1 by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-\u03b1 activity with lung fibrosis. Arthritis Rheumatism 58, 2163\u20132173 (2008).","journal-title":"Arthritis Rheumatism"},{"key":"10176_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1136\/ard.2009.121400","volume":"69","author":"M-L Eloranta","year":"2010","unstructured":"Eloranta, M.-L. et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis. Ann. Rheum. Dis. 69, 1396\u20131402 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"10176_CR30","first-page":"1","volume":"266","author":"M Wu","year":"2013","unstructured":"Wu, M. & Assassi, S. The Role of Type 1 Interferon in Systemic Sclerosis. Front. Immunol. 266, 1\u20137 (2013).","journal-title":"Front. Immunol."},{"key":"10176_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Van Bon","year":"2014","unstructured":"Van Bon, L. et al. Proteome-wide analysis and CXCL4 as a Biomarker in Systemic Sclerosis. N. Engl. J. Med 370, 433\u2013443 (2014).","journal-title":"N. Engl. J. Med"},{"key":"10176_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","volume":"10","author":"JCA Broen","year":"2014","unstructured":"Broen, J. C. A., Radstake, T. R. D. J. & Rossato, M. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat. Rev. Rheumatol. 10, 671\u2013681 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"10176_CR33","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","volume":"75","author":"Z Brkic","year":"2016","unstructured":"Brkic, Z. et al. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann. Rheum. Dis. 75, 1567\u20131573 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"10176_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam8458","volume":"10","author":"MD Ah Kioon","year":"2018","unstructured":"Ah Kioon, M. D. et al. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci. Transl. Med. 10, eaam8458 (2018).","journal-title":"Sci. Transl. Med."},{"key":"10176_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/BOR.0000000000000659","volume":"31","author":"F Barrat","year":"2019","unstructured":"Barrat, F. & Lu, T. Role of type I interferons and innate immunity in systemic sclerosis: unbalanced activities on distinct cell types?. Curr. Opin. Rheumatol. 31, 569\u2013575 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"10176_CR36","doi-asserted-by":"publisher","first-page":"154635","DOI":"10.1016\/j.cyto.2018.12.018","volume":"132","author":"B Skaug","year":"2020","unstructured":"Skaug, B. & Assassi, S. Type I interferon dysregulation in Systemic Sclerosis. Cytokine 132, 154635 (2020).","journal-title":"Cytokine"},{"key":"10176_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/BOR.0000000000000907","volume":"34","author":"V Kakkar","year":"2022","unstructured":"Kakkar, V. et al. Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Curr. Opin. Rheumatol. 34, 357\u2013364 (2022).","journal-title":"Curr. Opin. Rheumatol."},{"key":"10176_CR38","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.3390\/ijms21145102","volume":"21","author":"R Lande","year":"2020","unstructured":"Lande, R. et al. Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc type I interferon signature. IJMS 21, 5102 (2020).","journal-title":"IJMS"},{"key":"10176_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antib10020012","volume":"10","author":"R Lande","year":"2021","unstructured":"Lande, R. et al. New autoantibody specificities in systemic sclerosis and very early systemic sclerosis. Antibodies 10, 21\u201337 (2021).","journal-title":"Antibodies"},{"key":"10176_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/antib11040077","volume":"11","author":"R Palazzo","year":"2022","unstructured":"Palazzo, R. et al. Heparin-independent and heparin-dependent anti-CXCL4 antibodies have a reciprocal expression in a systemic sclerosis patients\u2019 cohort. Antibodies 11, 77 (2022).","journal-title":"Antibodies"},{"key":"10176_CR41","doi-asserted-by":"publisher","first-page":"111930","DOI":"10.1016\/j.celrep.2022.111930","volume":"42","author":"AL Gray","year":"2023","unstructured":"Gray, A. L. et al. Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors. Cell Rep. 42, 111930 (2023).","journal-title":"Cell Rep."},{"key":"10176_CR42","doi-asserted-by":"publisher","first-page":"160286","DOI":"10.1098\/rsob.160286","volume":"7","author":"DP Dyer","year":"2017","unstructured":"Dyer, D. P. et al. Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization. Open Biol. 7, 160286 (2017).","journal-title":"Open Biol."},{"key":"10176_CR43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230944","volume":"220","author":"\u00c7akan","year":"2023","unstructured":"\u00c7akan et al. TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance. J. Exp. Med 220, e20230944 (2023).","journal-title":"J. Exp. Med"},{"key":"10176_CR44","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/ijms24010653","volume":"24","author":"I Pietraforte","year":"2022","unstructured":"Pietraforte, I. et al. CXCL4-RNA complexes circulate in systemic sclerosis and amplify inflammatory\/pro-fibrotic responses by myeloid dendritic cells. Int. J. Mol. Sci. 24, 653 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"10176_CR45","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/annrheumdis-2014-206921","volume":"75","author":"L Yeo","year":"2016","unstructured":"Yeo, L. et al. Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis. Ann. Rheum. Dis. 75, 763\u2013771 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"10176_CR46","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1007\/s10620-015-3745-2","volume":"60","author":"H Takeyama","year":"2015","unstructured":"Takeyama, H. et al. Platelet activation markers are associated with Crohn\u2019s disease activity in patients with low C-reactive protein. Digest. Dis. Sci. 60, 3418\u20133423 (2015).","journal-title":"Digest. Dis. Sci."},{"key":"10176_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2332\/allergolint.O-08-537","volume":"57","author":"R Tamagawa-Mineoka","year":"2008","unstructured":"Tamagawa-Mineoka, R., Katoh, N., Ueda, E., Masuda, K. & Kishimoto, S. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of \u03b2-thromboglobulin and platelet factor. Allergol. Int. 57, 391\u2013396 (2008).","journal-title":"Allergol. Int."},{"key":"10176_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","volume":"125","author":"MA Kowalska","year":"2010","unstructured":"Kowalska, M. A., Rauova, L. & Poncz, M. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. Thrombosis Res. 125, 292\u2013296 (2010).","journal-title":"Thrombosis Res."},{"key":"10176_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jaut.2015.08.001","volume":"65","author":"MD Patsouras","year":"2015","unstructured":"Patsouras, M. D. et al. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome. J. Autoimmun. 65, 30\u201337 (2015).","journal-title":"J. Autoimmun."},{"key":"10176_CR50","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s10067-016-3386-7","volume":"35","author":"S Vettori","year":"2016","unstructured":"Vettori, S. et al. Serum CXCL4 increase in primary Sj\u00f6gren\u2019s syndrome characterizes patients with microvascular involvement and reduced salivary gland infiltration and lymph node involvement. Clin. Rheumatol. 35, 2591\u20132596 (2016).","journal-title":"Clin. Rheumatol."},{"key":"10176_CR51","doi-asserted-by":"crossref","unstructured":"Ye, L. et al. Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: a pilot study. Medicine 96, e6323 (2017).","DOI":"10.1097\/MD.0000000000006323"},{"key":"10176_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80685-4","volume":"11","author":"K Matsumoto","year":"2021","unstructured":"Matsumoto, K., Yasuoka, H., Yoshimoto, K., Suzuki, K. & Takeuchi, T. Platelet CXCL4 mediates neutrophil extracellular traps formation in ANCA-associated vasculitis. Sci. Rep. 11, 222 (2021).","journal-title":"Sci. Rep."},{"key":"10176_CR53","first-page":"125","volume":"33","author":"N-P Andreou","year":"2020","unstructured":"Andreou, N.-P. Inflammatory bowel disease pathobiology: the role of the interferon signature. Ann. Gastroenterol. 33, 125\u2013133 (2020).","journal-title":"Ann. Gastroenterol."},{"key":"10176_CR54","first-page":"65","volume":"6","author":"C Artlett","year":"2014","unstructured":"Artlett, C. Animal models of systemic sclerosis: their utility and limitations. Open Access Rheumatol. Res. Rev. 6, 65 (2014).","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"10176_CR55","doi-asserted-by":"crossref","unstructured":"Krauel, K. et al. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes. Blood 120, 3345\u20133352 (2012).","DOI":"10.1182\/blood-2012-06-434985"},{"key":"10176_CR56","unstructured":"Van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747 (2013)."},{"key":"10176_CR57","doi-asserted-by":"crossref","unstructured":"Diociaiuti, M. et al. Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1842, 1622\u20131629 (2014).","DOI":"10.1016\/j.bbadis.2014.06.006"},{"key":"10176_CR58","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1107\/S0021889812004037","volume":"45","author":"J Ilavsky","year":"2012","unstructured":"Ilavsky, J. Nika: software for two-dimensional data reduction. J. Appl. Crystallogr. 45, 324\u2013328 (2012).","journal-title":"J. Appl. Crystallogr."},{"key":"10176_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1107\/S1600576716000455","volume":"49","author":"AP Hammersley","year":"2016","unstructured":"Hammersley, A. P. FIT2D: a multi-purpose data reduction, analysis and visualization program. J. Appl. Crystallogr. 49, 646\u2013652 (2016).","journal-title":"J. Appl. Crystallogr."},{"key":"10176_CR60","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1021\/acsnano.7b05234","volume":"11","author":"EY Lee","year":"2017","unstructured":"Lee, E. Y. et al. Crystallinity of double-stranded RNA-antimicrobial peptide complexes modulates toll-like receptor 3 mediated inflammation. ACS Nano 11, 12145\u201312155 (2017).","journal-title":"ACS Nano"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10176-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10176-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:04:18Z","timestamp":1786363458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10176-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10176"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10176-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1061"}}